Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects-Reference-Cited by-同舟云学术

Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects

Published:2019-03 Issue:2 Volume:31 Page:75-88
ISSN:2529-9123
Container-title:Clínica e Investigación en Arteriosclerosis (English Edition)
language:en
Short-container-title:Clínica e Investigación en Arteriosclerosis (English Edition)

Author:

Hernández-Mijares Antonio,Ascaso Juan F.,Blasco Mariano,Brea Ángel,Díaz Ángel,Mantilla Teresa,Pedro-Botet Juan,Pintó Xavier,Millán Jesús

Publisher

Elsevier BV

Subject

General Medicine

Reference119 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

4. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors. The Prospective Pravastatin Pooling Project;Sacks;Circulation,2000

5. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. A randomised placebo-controlled trial;Lancet,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of high intensity intermittent training on lipid profile and blood glucose overweight/obese university students;Revista Cuidarte;2022-11-25

2. Residual Cardiovascular Risk Factors in Dyslipidemia;Cardiovascular Risk Factors [Working Title];2021-10-14

3. Triglicéridos: ¿son o no son un factor de riesgo cardiovascular?;Cardiovascular and Metabolic Science;2021

4. Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy;Pharmacology Research & Perspectives;2020-04